We are a consultancy firm offering services focused on the application of quantitative approaches to support drug research, development, and life-cycle decisions with the overall aim to improve patients’ lives. Our story began in 2012, when a team composed of experienced consultants, leaders from the pharmaceutical industry and researchers from Uppsala University formed Pharmetheus, Since then, our core business focus has broadened to support a wider range of model informed drug development (MIDD) activities across all phases of research and development and across a wide range of therapeutic areas. We continue to provide fit for purpose analyses and reports to support a wide variety of drug development decisions (such as dose selection, developing pediatric development plans, investigating the potential risk for QTc prolongation etc.). If you receive a job offer from an unknown source, not a verified Pharmetheus address, through text, messaging app, email or even LinkedIn, then it’s likely a scam! We will never contact you via unofficial channels, nor will we give direct offers without conducting a proper recruitment process. Always verify any offers through official company channels. Read more at www.pharmetheus.com Privacy policy: www.pharmetheus.com/privacy-policy/
Looking for a particular Pharmetheus employee's phone or email?
The Pharmetheus annual revenue was $16.4 million in 2026.
Emma Ångström is the CFO of Pharmetheus.
102 people are employed at Pharmetheus.
The NAICS codes for Pharmetheus are [32541, 32, 325, 3254].
The SIC codes for Pharmetheus are [28, 283].